Research Article

Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children

Table 1

Demographic and clinical characteristics of the subjects enrolled excluding those lost to follow-up.

HIV-uninfected childrenHIV-infected childrenHealthy adult donors
Culture-confirmedHighly probableProbableTotal active TBRespiratory diseasesCulture-confirmedHighly probableProbableTotal active TBRespiratory diseases

(%)77519610103131833

Median age (IQR)12 (9–15)8 (1–14)3 (1–8)8 (2–14)4 (2–8)8 (1–14)149 (4–14)5 (3–8)26 (23–30)

Male gender (%)3 (42.8)4 (57.1)2 (40.0)9 (47.4)34 (56.7)4 (30.8)8 (44.4)12 (46.2)

TB localization
 Pulmonary (PTB) 7 (100)6 (85.7)5 (100)18 (94.7)0 (0)10 (100)3 (100)13 (100)
 Extrapulmonary (ETB) 0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)0 (0)
 PTB and EPT0 (0)1 (14.3)0 (0)1 (5.3)0 (0)0 (0)0 (0)0 (0)

Diseases other than TB
 Pneumonia24 (39.3)8 (44.5)
 Respiratory tract infections20 (32.8)4 (22.2)
 Miscellanea17 (27.9)6 (33.3)

CD4+T-cell/mm3
Median (IQR)
388 (328–536)184
(NA)
386 (243–580)583 (480–831)

Urinary parameters
Median (IQR)
 Creatinuria43.4 (27.0–65.1)41.1 (26.6–81.6)18.6 (11.2–36.7)38.3 (18.6–65.1)28.7 (12.5–49.6)30.5 (9.4–72.9)59.8
(NA)
37.7 (13.3–69.6)37.8 (6.9–48.9)105.0 (81.4–137.2)
 Specific gravity1.01 (1.01–1.02)1.02 (1.01–1.02)1.02 (1.01–1.03)1.02 (1.01–1.02)1.01 (1.01–1.02)1.01 (1.01–1.02)1.02
(NA)
1.01 (1.01–1.02)1.02 (1.02–1.03)1.02 (1.02–1.03)
 pH6.0 (6.0–6.5)6.3
(6.0–7.3)
6.0
(6.0–7.0)
6
(6.0–6.6)
6.5 (6.0–8.0)6.0 (6.0–6.6)6.0
(NA)
6.0 (6.0–6.8)6.0 (6.0–6.6)7.0
(6.0–8.0)

TB: tuberculosis; IQR: interquartile range; HIV: Human Immunodeficiency Virus; QFT-IT: QuantiFERON TB-Gold In-Tube; TST: tuberculin skin test.